However, when the ferroptosis inducer Erastin was administered to RCC cells, a more pronounced ferroptosis effect was observed in the VDAC2 overexpression group, characterized by iron accumulation, MDA overproduction, and GSH depletion (169). Here, VDAC2 is linked to renal cell carcinoma.